Bevacizumab Increases the Risk of Severe Congestive Heart Failure in Cancer Patients: An Up-to-Date Meta-Analysis with a Focus on Different Subgroups Wei-Xiang QiShen FuXiao-Mao Guo Systematic Review 06 August 2014 Pages: 681 - 690
Evaluation of the Potential for a Pharmacokinetic Drug–Drug Interaction Between Armodafinil and Ziprasidone in Healthy Adults Mona DarwishMary BondPhilmore Robertson Jr. Original Research Article 22 July 2014 Pages: 691 - 699
Triple Combination Therapy in Hypertension: The Antihypertensive Efficacy of Treatment with Perindopril, Amlodipine, and Indapamide SR Dénes PállIldikó SzántóZoltán Szabó Original Research Article 12 September 2014 Pages: 701 - 708
Cost Effectiveness of Apixaban Versus Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in Belgium Thitima KongnakornTereza LanitisSophie Marbaix Original Research Article 28 August 2014 Pages: 709 - 721
Evaluation of the Effect of Multiple Doses of Lansoprazole on the Pharmacokinetics and Safety of Ponatinib in Healthy Subjects Narayana I. NarasimhanDavid J. DorerDaryl Sonnichsen Original Research Article 22 August 2014 Pages: 723 - 729
Pharmacokinetic and Pharmacodynamic Profiles of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment Nobuya InagakiKazuoki KondoKenichi Furihata Original Research Article Open access 09 September 2014 Pages: 731 - 742
Population Pharmacokinetics and Dose–Exposure Proportionality of Edoxaban in Healthy Volunteers Ophelia Q. P. YinRaymond Miller Original Research Article 04 September 2014 Pages: 743 - 752
Erratum to: Cost Effectiveness of Apixaban Versus Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in Belgium Thitima KongnakornTereza LanitisSophie Marbaix Erratum 10 September 2014 Pages: 753 - 753
